Advertisement
Screener

Odyssey Therapeutics, Inc. (ODTX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

Odyssey Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

Odyssey Therapeutics, Inc. (ODTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $65.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-06

  • 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $65.37M.
  • 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $4.41M.
  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $4.61M.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
2026-06-30$65.37M
10-Q · filed 2026-08-06
2026-03-31$4.41M
10-Q · filed 2026-06-17
2025-12-31$4.61M
10-Q · filed 2026-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Replimune Group, Inc. (REPL)United States$1.186B-3.13
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10